Loading...
11 results
Search Results
Now showing 1 - 10 of 11
- Genes, Crianças e Pediatras IVPublication . Soares, G.; Pimentel, I.; Dias, C.; Pinto-Basto, J.; Martins, M.; Fortuna, A.; Reis-Lima, M.
- Genes, Crianças e Pediatras 2005 IIPublication . Dias, C.; Martins, M.; Rocha, M.; Soares, G.; Pinto-Basto, J.; Gonçalves, S.; Carrilho, I.; Fortuna, A.; Reis-Lima, M.
- Desenvolvimento neurocognitivo em 99 adolescentes e adultos com fenilcetonúria: ganhos em saúde resultantes de uma abordagem multidisciplinarPublication . Carmona, C.M.; Almeida, M.F.; Rocha, J.C.; Soares, G.; Fortuna, A.
- Unraveling the pathogenesis of ARX polyalanine tract variants using a clinical and molecular interfacing approachPublication . Marques, I.; Sá, J.; Soares, G.; Mota, M.; Pinheiro, C.; Aguiar, L.; Amado, M.; Soares, C.; Calado, A.; Dias, P.; Sousa, A.; Fortuna, A.; Santos, R.; Howell, K.; Ryan, M.; Leventer, R.; Sachdev, R.; Catford, R.; Friend, K; Mattiske, T.; Shoubridge, C.; Jorge, P.The Aristaless-related homeobox (ARX) gene is implicated in intellectual disability with the most frequent pathogenic mutations leading to expansions of the first two polyalanine tracts. Here, we describe analysis of the ARX gene outlining the approaches in the Australian and Portuguese setting, using an integrated clinical and molecular strategy. We report variants in the ARX gene detected in 19 patients belonging to 17 families. Seven pathogenic variants, being expansion mutations in both polyalanine tract 1 and tract 2, were identifyed, including a novel mutation in polyalanine tract 1 that expands the first tract to 20 alanines. This precise number of alanines is sufficient to cause pathogenicity when expanded in polyalanine tract 2. Five cases presented a probably non-pathogenic variant, including the novel HGVS: c.441_455del, classified as unlikely disease causing, consistent with reports that suggest that in frame deletions in polyalanine stretches of ARX rarely cause intellectual disability. In addition, we identified five cases with a variant of unclear pathogenic significance. Owing to the inconsistent ARX variants description, publications were reviewed and ARX variant classifications were standardized and detailed unambiguously according to recommendations of the Human Genome Variation Society. In the absence of a pathognomonic clinical feature, we propose that molecular analysis of the ARX gene should be included in routine diagnostic practice in individuals with either nonsyndromic or syndromic intellectual disability. A definitive diagnosis of ARX-related disorders is crucial for an adequate clinical follow-up and accurate genetic counseling of at-risk family members.
- Genes, Crianças e Pediatras IIIPublication . Dias, C.; Soares, G.; Pinto-Basto, J.; Fortuna, A.; Martins, M.; Reis-Lima, M.; Fonseca, F.
- Arx-related disorders: several distinct phenotypes, one mutated genePublication . Sá, M.J.; Soares, G.; Silva, J.; Fortuna, A.; Santos, R.; Marques, I.; Jorge, P.
- Genes, crianças e pediatras: Neurofibromatose tipo 1Publication . Barbosa, M.; Pinto-Basto, J.; Lima, M.; Fortuna, A.; Soares, G.Criança do sexo masculino avaliada pela primeira vez na consulta de Genética aos 4 anos e 4 meses, com de manchas café com leite, efélides axilares e inguinais, convulsões e compromisso do desenvolvimento psicomotor. A mãe do doente apresenta QI borderline, manchas café com leite, neurofi bromas, axilar e inguinal, nódulos de Lisch e glioma do nervo óptico.
- Genes, crianças e pediatras: síndrome de Silver RusselPublication . Gonçalves-Rocha, M.; Silva, J.; Fortuna, A.; Soares, G.
- Genes, Crianças e Pediatras, 2005 IPublication . Pinto-Basto, J.; Martins, T.; Soares, G.; Dias, C.; Rocha, M.; Martins, M.; Fortuna, A.; Reis-Lima, M.
- A 26-Year Experience in Chorionic Villus Sampling Prenatal Genetic DiagnosisPublication . Jorge, P.; Mota-Freitas, M.; Santos, R.; Silva, M.; Soares, G.; Fortuna, A.Abstract: This report describes the trends of chorionic villus sampling (CVS) referred for prenatal genetic diagnosis in the past two and a half decades in a Portuguese Center. Our cohort of 491 CVS was mostly performed by the transcervical method at the 12th gestational week. Data collected within the framework of this study relate to the following: sampling method, referral reason versus abnormality and incidence of procedure-related pregnancy loss, that declined to about 0.5% over the last 15 years. The year 2000 represented a change in referral reasons for chorionic tissue collection, shifting from almost exclusively for cytogenetic testing to an increasing number of molecular tests for monogenic disorders. Herein, success rates as well as cytogenetic and/or molecular DNA results are presented. These latter include not only tests for several monogenic disorders, but also aneuploidy and maternal cell contamination screening. This retrospective analysis reiterates that CVS is a safe and reliable first trimester technique for prenatal diagnosis in high genetic risk pregnancies.